News
How Innovation Can Address Global Threats to Access Posed by Climate Crisis
CTI Exchange Youth Engagement at ICFP
Recent Contraceptive Research and Development Funding Announcements
Official Video Release: We Don’t Have Bad Blood!
Updated Couple Years of Protection: Literature Review and Guidance
New report brings human rights perspectives to LARC service provision in the UK
New report examines the strengths and weaknesses of SRH supply chains during COVID-19
Highlighting the drospirenone progestin-only pill
Mirena levonorgestrel-releasing intrauterine system now approved for 6 years of pregnancy prevention
Special issue of Biology of Reproduction highlights contraceptive development
The FDA Approves the First Non-Hormonal Prescription Birth Control Gel, Phexxi™
Trials Methodology Research Partnership Grant – now OPEN!
Predicting Menopause: There Just May be a Test for That
Amphora Shows Promise in Clinical Trials
U.S. Food and Drug Administration Approves First Generic Contraceptive Vaginal Ring
Microneedle Patch Delivers Long-Acting Reversible Contraception
Is a once-a-month birth control pill on the horizon?
Takeaways from the 2019 FDA Complex Generic Drug Product Development Workshop
LILETTA® levonorgestrel-releasing intrauterine system now FDA-approved for use for up to 6 years
The Initiative for Multipurpose Prevention Technologies (IMPT) Ten-Year Retrospective Report
Pressing Pause on Your Fertility: Contraception via Egg Hibernation
The Demographic and Health Surveys (DHS) Program Updates Questionnaires
NICHD Releases Five-Year Strategic Plan
Rebuilding Incentives for Research and Development of Medicines
ECHO Trial Results Show that Three Methods Do Not Increase Risk of HIV
Planning for Outcomes Tool Helps Estimate Impact of Changing Contraceptive Method Mix
One contraceptive for both men and women
Ovaprene® holds promise as non-hormonal contraceptive
Potential role of genetics in contraceptive failure
Contraceptive Jewelry Under Development
It’s an exciting time at the CTI Exchange!
DHS Program Seeks Feedback on Model Questionnaires
NICHD Solicits Feedback on Strategic Plan
Microneedle patches designed to deliver long-acting contraceptive hormone
FDA plans new office to revamp drug review process
International Conference on Family Planning
Launch of first clinical trial for male contraceptive gel
Celebrating #NextGenContraception on World Contraception Day
FDA approvals for Annovera and Natural Cycles app
New Summer Twitter Campaign: #NextGenContraception
Report on the International Family Planning Landscape
Newly Published Results of a Phase I/II Trial for LNG-only Patches
Published Review on Responses to Contraceptive-Induced Menstrual Changes
Vaginal Ring Dose-Finding Results Published
Sperm Motility Inhibited in Study of Male Macaques
Daré Bioscience & Orbis Biosciences to Collaborate on Injectables
Family Planning Global Handbook Updated
Contraceptive Implant Strategic Partnership Announced
FDA Proposes Female Condom Rule Change
FDA to Review One-year Vaginal Ring